文献速递疼痛医学神经外科与老年麻醉

脊髓电刺激通过外周神经保护机制减轻紫杉醇诱导的步态障碍和机械性超敏反应

Spinal cord stimulation attenuates paclitaxel-induced gait impairment and mechanical hypersensitivity via peripheral neuroprotective mechanisms in tumor-bearing rats.
PubMed 文献 · Reg Anesth Pain Med · 2025-08-05

本研究在荷瘤RNU大鼠中探讨脊髓电刺激(SCS)对紫杉醇(PTX)诱导的步态障碍和机械性超敏反应的作用及外周神经保护机制。SCS(50 Hz,0.2 ms,80%运动阈值)可减轻机械性超敏反应和步态障碍,并减少施万细胞丢失和巨噬细胞介导的神经炎症。

要点

  • SCS可减轻PTX诱导的机械性超敏反应和步态障碍。
  • SCS减少坐骨神经中施万细胞丢失和巨噬细胞浸润。
  • SCS上调抗炎细胞因子IL-10并调节相关基因表达。

核心结论

  • SCS可能通过减少施万细胞丢失和巨噬细胞介导的神经炎症来减轻PTX诱导的疼痛和步态障碍。

研究设计与样本

  • 研究使用成年雄性荷瘤Rowlette Nude(RNU)大鼠,评估PTX治疗和SCS的效果。
  • 每周评估步态和机械性超敏反应,并检测坐骨神经中细胞因子、基因表达、巨噬细胞浸润和极化、神经形态和施万细胞。

主要发现

  • SCS(50 Hz,0.2 ms,80%运动阈值)减轻机械性超敏反应(20.93±0.80 vs 12.23±2.71克,p<0.0096)。
  • SCS改善步态障碍:摆动时间(90.41±7.03 vs 117.27±9.71%,p<0.0076)和单支撑时间(94.92±3.62 vs 112.75±7.27%,p<0.0245)。
  • SCS减少施万细胞丢失和髓鞘厚度降低,增加抗炎细胞因子IL-10浓度。
  • RNA测序显示SCS后607个基因(59.2%)上调,418个基因(40.8%)下调。

临床怎么用

  • SCS可能作为PTX诱导的化疗周围神经病变相关疼痛和步态障碍的潜在治疗选择。
  • SCS参数(50 Hz,0.2 ms,80%运动阈值)在动物模型中显示有效,但临床转化需进一步研究。

局限性

  • 研究为动物实验,结果需在临床试验中验证。
  • 样本量未在摘要中报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Taxanes such as paclitaxel (PTX) induce dose-dependent chemotherapy-induced peripheral neuropathy (CIPN), which is associated with debilitating chronic pain and gait impairment. Increased macrophage-related proinflammatory activities have been reported to mediate the development and maintenance of neuropathic pain. While spinal cord stimulation (SCS) has been used for a number of pain conditions, the mechanisms supporting its use for CIPN remain to be elucidated. Thus, we aimed to examine whether SCS can attenuate Schwann cell-mediated and macrophage-mediated neuroinflammation in the sciatic nerve of Rowlette Nude (RNU) rats with PTX-induced gait impairment and mechanical hypersensitivity. METHODS: Adult male tumor-bearing RNU rats were used for this study examining PTX treatment and SCS. Gait and mechanical hypersensitivity were assessed weekly. Cytokines, gene expression, macrophage infiltration and polarization, nerve morphology and Schwann cells were examined in sciatic nerves using multiplex immunoassay, bulk RNA sequencing, histochemistry and immunohistochemistry techniques. RESULTS: SCS (50 Hz, 0.2 milliseconds, 80% motor threshold) attenuated the development of mechanical hypersensitivity (20.93±0.80 vs 12.23±2.71 grams, p<0.0096) and temporal gait impairment [swing (90.41±7.03 vs 117.27±9.71%, p<0.0076), and single stance times (94.92±3.62 vs 112.75±7.27%, p<0.0245)] induced by PTX (SCS+PTX+Tumor vs Sham SCS+PTX+Tumor). SCS also attenuated the reduction in Schwann cells, myelin thickness and increased the concentration of anti-inflammatory cytokine interleukin (IL)-10. Bulk RNA sequencing revealed differential gene expression after SCS, with 607 (59.2%) genes upregulated while 418 (40.8%) genes were downregulated. Notably, genes related to anti-inflammatory cytokines and neuronal growth were upregulated, while genes related to proinflammatory-promoting genes, increased M2γ polarization and decreased macrophage infiltration and Schwann cell loss were downregulated. CONCLUSION: SCS may attenuate PTX-induced pain and temporal gait impairment, which may be partly attributed to decreases in Schwann cell loss and macrophage-mediated neuroinflammation in sciatic nerves.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Bakare AO, Stephens K, Sanchez KR, et al. Spinal cord stimulation attenuates paclitaxel-induced gait impairment and mechanical hypersensitivity via peripheral neuroprotective mechanisms in tumor-bearing rats. Reg Anesth Pain Med. 2025. PMID: 38844412. doi:10.1136/rapm-2024-105433

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。